Nifty

:

11050.25

Sensex

:

37388.66

244.70 (2.26%)
835.06 (2.28%)

Login

Nifty
Sensex

:
:

11050.25
37388.66

244.70 (2.26%)
835.06 (2.28%)

Krebs Biochemicals & Industries Ltd.

Pharmaceuticals & Drugs

Rating :

65/99

BSE: 524518 | NSE: KREBSBIO

Watchlist

NSE BSE

86.95

25-Sep-2020

Open
High
Low
Previous Close

87.25
88.00
84.95
85.05

Volume
Traded Value (lacs)
52 Week High
52 Week Low

1290
1.13
111.35
60.65

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

172.66
N/A
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

208.72
N/A
-7.14

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

0.33
-
138.28

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
14.78
4.06

PAT CAGR (%)

10 Years
5 Years
3 Years

13.44
20.61
7.63

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

-8.09
-8.09
-8.09

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-1.87
-20.55
-27.82

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 11.57 4.66 148.28% 14.75 11.71 25.96% 7.55 11.34 -33.42% 6.45 15.76 -59.07%
Expenses 15.87 9.67 64.12% 18.79 14.11 33.17% 12.00 15.40 -22.08% 11.59 16.32 -28.98%
EBITDA -4.30 -5.01 - -4.03 -2.40 - -4.45 -4.05 - -5.13 -0.56 -
EBIDTM -37.19% -107.53% -27.34% -20.53% -59.00% -35.75% -79.54% -3.54%
Other Income 0.05 0.18 -72.22% 0.10 0.16 -37.50% 0.02 0.12 -83.33% 0.07 0.02 250.00%
Interest 1.23 1.61 -23.60% 0.99 1.90 -47.89% 1.70 1.46 16.44% 1.63 1.46 11.64%
Depreciation 1.24 1.15 7.83% 1.23 1.18 4.24% 1.15 1.07 7.48% 1.15 1.07 7.48%
PBT -6.72 -7.59 - -6.16 -5.21 - -7.28 -6.46 - -7.85 -3.07 -
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT -6.72 -7.59 - -6.16 -5.21 - -7.28 -6.46 - -7.85 -3.07 -
PATM -58.09% -162.81% -41.73% -44.48% -96.49% -56.98% -121.60% -19.51%
EPS -3.43 -3.87 - -3.14 -2.66 - -3.71 -3.30 - -4.00 -1.57 -

Description Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var% Jun 19 Jun 18 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Sep 14 Jun 13 Mar 12 Mar 11 Mar 10
Net Sales 40.32 47.76 33.78 3.53 1.29 0.00 0.00 11.45 70.76 72.44 46.23 Net Sales Growth -7.25% 41.39% 856.94% 173.64% 0 0 -100% -83.82% -2.32% 56.69% Cost Of Goods Sold 17.24 23.10 12.67 1.20 0.14 0.00 0.00 4.61 38.70 40.69 18.64 Gross Profit 23.08 24.65 21.10 2.33 1.14 0.00 0.00 6.83 32.06 31.76 27.59 GP Margin 57.25% 51.61% 62.46% 66.01% 88.37% 0 0 59.65% 45.31% 43.84% 59.68% Total Expenditure 58.25 57.52 41.28 11.53 13.69 4.90 4.04 24.63 74.54 72.24 44.11 Power & Fuel Cost - 11.70 8.62 0.70 2.87 0.28 1.87 6.24 18.79 12.99 9.19 % Of Sales - 24.50% 25.52% 19.83% 222.48% 0 0 54.50% 26.55% 17.93% 19.88% Employee Cost - 14.41 11.49 5.63 5.67 1.86 0.55 9.08 8.77 8.28 6.62 % Of Sales - 30.17% 34.01% 159.49% 439.53% 0 0 79.30% 12.39% 11.43% 14.32% Manufacturing Exp. - 4.09 4.59 1.07 1.62 0.62 0.04 1.76 3.57 4.27 3.06 % Of Sales - 8.56% 13.59% 30.31% 125.58% 0 0 15.37% 5.05% 5.89% 6.62% General & Admin Exp. - 4.05 3.76 2.88 3.33 2.14 1.54 2.57 2.36 2.46 2.18 % Of Sales - 8.48% 11.13% 81.59% 258.14% 0 0 22.45% 3.34% 3.40% 4.72% Selling & Distn. Exp. - 0.13 0.13 0.05 0.04 0.00 0.01 0.29 2.31 2.42 2.29 % Of Sales - 0.27% 0.38% 1.42% 3.10% 0 0 2.53% 3.26% 3.34% 4.95% Miscellaneous Exp. - 0.02 0.02 0.01 0.02 0.00 0.03 0.06 0.04 1.11 2.29 % Of Sales - 0.04% 0.06% 0.28% 1.55% 0 0 0.52% 0.06% 1.53% 4.56% EBITDA -17.91 -9.76 -7.50 -8.00 -12.40 -4.90 -4.04 -13.18 -3.78 0.20 2.12 EBITDA Margin -44.42% -20.44% -22.20% -226.63% -961.24% 0 0 -115.11% -5.34% 0.28% 4.59% Other Income 0.24 0.33 0.21 0.08 1.03 0.01 0.18 6.14 2.75 7.02 0.03 Interest 5.55 6.29 5.17 3.49 0.74 4.03 0.08 0.63 8.66 7.52 6.95 Depreciation 4.77 4.40 4.15 4.23 4.49 1.87 0.00 8.28 9.66 9.60 9.88 PBT -28.01 -20.12 -16.61 -15.65 -16.60 -10.79 -3.95 -15.94 -19.34 -9.89 -14.68 Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.40 -0.74 -1.90 -3.21 -9.01 Tax Rate 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -10.13% 4.64% 9.82% 32.46% 61.38% PAT -28.01 -20.01 -17.82 -16.05 -16.32 -7.84 -4.35 -15.20 -17.44 -6.68 -5.67 PAT before Minority Interest -28.01 -20.01 -17.82 -16.05 -16.32 -7.84 -4.35 -15.20 -17.44 -6.68 -5.67 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -69.47% -41.90% -52.75% -454.67% -1265.12% 0 0 -132.75% -24.65% -9.22% -12.26% PAT Growth 0.00% - - - - - - - - - EPS -14.29 -10.21 -9.09 -8.19 -8.33 -4.00 -2.22 -7.76 -8.90 -3.41 -2.89

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Sep 14 Jun 13 Mar 12 Mar 11 Mar 10
Shareholder's Funds -14.29 -17.78 1.48 13.01 18.28 3.60 7.95 23.15 40.59 45.97 Share Capital 16.63 13.74 13.74 13.06 9.51 9.51 9.51 9.51 9.05 9.05 Total Reserves -30.92 -31.52 -12.27 -3.72 -14.08 -5.91 -1.57 13.64 30.24 36.92 Non-Current Liabilities 101.79 101.37 88.88 73.88 60.12 23.02 57.33 65.53 73.31 90.97 Secured Loans 0.00 1.89 5.03 21.40 14.00 15.00 48.70 59.09 64.94 75.67 Unsecured Loans 50.23 49.78 37.76 3.91 43.61 7.32 8.35 5.67 5.91 11.05 Long Term Provisions 4.04 3.68 2.82 3.57 3.83 2.02 2.00 1.74 1.53 0.00 Current Liabilities 54.86 42.28 31.72 29.52 28.72 109.84 70.64 58.93 42.91 20.86 Trade Payables 21.46 17.76 10.99 12.37 16.54 19.79 19.75 27.34 20.98 15.71 Other Current Liabilities 31.97 23.27 19.86 16.34 12.09 84.67 31.92 16.26 6.48 3.86 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 3.48 18.73 15.17 15.13 0.00 Short Term Provisions 1.43 1.25 0.87 0.82 0.09 1.90 0.24 0.16 0.33 1.29 Total Liabilities 142.36 125.87 122.08 116.41 107.12 136.46 135.92 147.61 156.81 157.80 Net Block 101.27 100.77 102.17 93.10 50.98 50.58 50.63 58.47 66.14 68.79 Gross Block 234.41 229.51 226.55 213.24 166.84 164.25 164.31 163.87 161.88 154.94 Accumulated Depreciation 133.15 128.74 124.38 120.14 115.86 113.66 113.67 105.40 95.74 86.15 Non Current Assets 111.39 108.64 109.10 107.03 92.26 97.66 97.49 104.59 108.58 72.47 Capital Work in Progress 3.48 3.73 3.50 10.54 7.46 7.13 7.13 6.96 5.00 3.69 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 6.22 3.72 3.23 3.19 33.82 39.95 39.73 39.16 37.45 0.00 Other Non Current Assets 0.41 0.41 0.20 0.20 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 30.98 17.24 12.97 9.39 14.87 38.81 38.43 43.02 48.23 80.33 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 8.96 11.73 5.45 5.64 5.45 30.82 30.82 30.49 29.40 29.37 Sundry Debtors 2.91 0.32 1.59 0.03 0.37 0.62 0.92 7.74 13.39 28.27 Cash & Bank 17.32 0.42 0.12 0.27 6.31 0.36 0.33 0.43 0.37 0.51 Other Current Assets 1.78 0.33 0.14 0.08 2.74 7.01 6.35 4.36 5.08 22.18 Short Term Loans & Adv. 1.57 4.44 5.67 3.38 0.59 5.41 4.91 2.88 4.15 22.18 Net Current Assets -23.88 -25.04 -18.74 -20.14 -13.86 -71.03 -32.21 -15.92 5.32 59.47 Total Assets 142.37 125.88 122.07 116.42 107.13 136.47 135.92 147.61 156.81 157.80

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Sep 14 Jun 13 Mar 12 Mar 11 Mar 10
Cash From Operating Activity -3.67 -6.19 -11.20 -15.26 -45.26 49.24 -1.55 7.32 -4.62 -15.51 PBT -20.12 -16.61 -16.05 -16.60 -10.79 -4.10 -15.94 -19.34 -9.89 -14.76 Adjustment 9.10 6.46 10.67 3.45 8.84 0.22 2.76 15.56 10.05 13.21 Changes in Working Capital 13.59 9.12 -2.33 -1.38 -39.28 54.65 12.37 19.82 1.61 -7.06 Cash after chg. in Working capital 2.57 -1.02 -7.71 -14.53 -41.23 50.76 -0.81 16.04 1.78 -8.61 Interest Paid -6.24 -5.17 -3.49 -0.74 -4.03 -1.53 -0.63 -8.66 -7.47 -6.90 Tax Paid 0.00 0.00 0.00 0.00 0.00 0.00 -0.11 -0.06 1.07 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -4.32 -2.77 -4.70 -4.00 -2.92 0.07 5.54 -1.20 3.76 11.55 Net Fixed Assets -4.65 -3.19 -6.27 -49.48 -2.92 0.06 -0.61 -3.95 -8.25 11.72 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others 0.33 0.42 1.57 45.48 0.00 0.01 6.15 2.75 12.01 -0.17 Cash from Financing Activity 24.88 9.26 15.75 13.22 54.13 -49.28 -4.09 -6.06 0.72 4.05 Net Cash Inflow / Outflow 16.90 0.30 -0.15 -6.04 5.95 0.03 -0.10 0.07 -0.14 0.09 Opening Cash & Equivalents 0.42 0.12 0.27 6.31 0.36 0.33 0.43 0.37 0.51 0.42 Closing Cash & Equivalent 17.32 0.42 0.12 0.27 6.31 0.36 0.33 0.43 0.37 0.51

Financial Ratios

Standalone

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Sep 14 Jun 13 Mar 12 Mar 11 Mar 10
Book Value (Rs.) -8.59 -12.49 1.04 6.91 -4.63 3.66 8.07 23.50 41.93 43.73 ROA -14.92% -14.38% -13.46% -14.60% -6.44% -3.19% -10.72% -11.46% -4.25% -3.44% ROE 0.00% 0.00% -296.70% -683.34% 0.00% -75.26% -97.77% -55.86% -16.65% -12.93% ROCE -35.41% -28.95% -27.13% -25.38% -4.33% -3.91% -14.60% -9.06% -1.86% -6.01% Fixed Asset Turnover 0.21 0.15 0.02 0.01 0.00 0.00 0.07 0.47 0.49 0.30 Receivable days 12.36 10.34 83.55 51.87 0.00 0.00 130.58 50.71 97.10 220.67 Inventory Days 79.07 92.84 573.34 1435.63 0.00 0.00 925.22 143.77 137.01 192.97 Payable days 123.25 120.44 290.43 338.13 1500.06 2505.25 277.77 107.23 85.09 103.10 Cash Conversion Cycle -31.81 -17.27 366.46 1149.37 -1500.06 -2505.25 778.03 87.24 149.02 310.53 Total Debt/Equity -3.74 -3.16 32.19 3.27 -13.34 25.86 11.65 3.72 2.19 2.12 Interest Cover -2.18 -2.45 -3.60 -21.09 -0.95 -45.92 -24.33 -1.23 -0.32 -1.11

Top Investors:

sun pharmaceuticals industries limited

deep investrade (bombay) private limited

shaaji paliyaat

Annual Reports:

News Update:

No Latest News!

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback